Tivic Health Systems, Inc. - Common stock (NQ:TIVC)

0.9251 -0.2149 (-18.85%)

Streaming Delayed Price Updated: 3:43 PM EDT, Mar 26, 2026 Add to My Watchlist

Price and Volume

Volume	128,716
Open	0.9668
Bid (Size)	0.9151 (100)
Ask (Size)	0.9911 (100)
Prev. Close	1.140
Today's Range	0.8906 - 1.025
52wk Range	0.7217 - 13.23
Shares Outstanding	29,677,734
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome

Today 8:30 EDT

Via ACCESS Newswire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

March 25, 2026

Via Chartmill

Performance

YTD	-34.9%	-34.9%
1 Month	+24.2%	+24.2%
3 Month	-51.1%	-51.1%
6 Month	-69.6%	-69.6%
1 Year	-71.2%	-71.2%

More News

Tivic Reports Full Year 2025 Results

March 25, 2026

Via ACCESS Newswire

Tivic Health CEO Letter to Shareholders

March 24, 2026

Via ACCESS Newswire

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

March 20, 2026

Via ACCESS Newswire

These stocks have an unusual volume in today's session ↗

March 11, 2026

Via Chartmill

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

March 10, 2026

Via Chartmill

Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma

March 04, 2026

Via ACCESS Newswire

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

February 18, 2026

Via ACCESS Newswire

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

January 23, 2026

Via ACCESS Newswire

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

January 20, 2026

Via ACCESS Newswire

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

January 12, 2026

Via ACCESS Newswire

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

January 08, 2026

Via ACCESS Newswire

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

December 11, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 18, 2025

Via Benzinga

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

November 18, 2025

Via ACCESS Newswire

Tivic Reports Third Quarter 2025 Financial Results

November 14, 2025

Via ACCESS Newswire

Earnings Scheduled For November 14, 2025 ↗

November 14, 2025

Via Benzinga

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

November 13, 2025

Via ACCESS Newswire

Tivic Expands Intellectual Property Portfolio

November 10, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

November 06, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

October 22, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference

September 22, 2025

From Tivic Health Systems, Inc.

Via Business Wire

Stay updated with the stocks that are on the move in today's after-hours session. ↗

September 17, 2025

Via Chartmill

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

September 10, 2025

From Tivic Health® Systems, Inc.

Via Business Wire

Frequently Asked Questions

Is Tivic Health Systems, Inc. - Common stock publicly traded?

Yes, Tivic Health Systems, Inc. - Common stock is publicly traded.

What exchange does Tivic Health Systems, Inc. - Common stock trade on?

Tivic Health Systems, Inc. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Tivic Health Systems, Inc. - Common stock?

The ticker symbol for Tivic Health Systems, Inc. - Common stock is TIVC on the Nasdaq Stock Market

What is the current price of Tivic Health Systems, Inc. - Common stock?

The current price of Tivic Health Systems, Inc. - Common stock is 0.9251

When was Tivic Health Systems, Inc. - Common stock last traded?

The last trade of Tivic Health Systems, Inc. - Common stock was at 03/26/26 03:43 PM ET

What is the market capitalization of Tivic Health Systems, Inc. - Common stock?

The market capitalization of Tivic Health Systems, Inc. - Common stock is 27.45M

How many shares of Tivic Health Systems, Inc. - Common stock are outstanding?

Tivic Health Systems, Inc. - Common stock has 27M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.